Facts
- Product: Plaster with porous micro needles
- Sector: Life Sciences & Health
- Founded: 2012
- Amount invested: € 300,000
- Status: Active
Micro needle patches as an alternative to needle injections and oral medication
Certain groups of drugs and vaccines are currently administered almost exclusively through needle injections, but this has a number of drawbacks. It is painful and people who suffer from needle anxiety may even refuse therapy. Furthermore, administration through syringes requires medical training.
MyLife Technologies has developed an alternative to needle injections and oral medication for administering medicines. Its micro needle patches allow for self-administration through the skin by the patient and are minimally invasive. In the case of vaccines, administration through the skin offers additional advantages because it allows the active substances to effectively target immune cells in the skin, which may result in a better immune response. The plaster administers medicines and vaccines without the patient experiencing any pain or discomfort and can also, to a large degree, eliminate the limitations of existing pharmaceutical patches.